LFMD LifeMD Inc

Price (delayed)

$6.68

Market cap

$282.5M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.74

Enterprise value

$267.29M

LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable ...

Highlights
The gross profit has grown by 37% YoY and by 8% from the previous quarter
The revenue has grown by 33% YoY and by 7% from the previous quarter
LifeMD's equity has shrunk by 124% QoQ but it has surged by 93% YoY
The quick ratio has soared by 69% YoY but it has contracted by 17% from the previous quarter
The debt is up by 21% year-on-year and by 5% since the previous quarter

Key stats

What are the main financial stats of LFMD
Market
Shares outstanding
42.29M
Market cap
$282.5M
Enterprise value
$267.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
Earnings
Revenue
$163.56M
EBIT
-$20.12M
EBITDA
-$12.79M
Free cash flow
$7.67M
Per share
EPS
-$0.74
Free cash flow per share
$0.2
Book value per share
-$0.02
Revenue per share
$4.17
TBVPS
$1.19
Balance sheet
Total assets
$61.46M
Total liabilities
$60.16M
Debt
$19.9M
Equity
-$845,303
Working capital
-$266,333
Liquidity
Debt to equity
-23.55
Current ratio
0.99
Quick ratio
0.91
Net debt/EBITDA
1.19
Margins
EBITDA margin
-7.8%
Gross margin
88.2%
Net margin
-14.3%
Operating margin
-10.9%
Efficiency
Return on assets
-54%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-119.9%
Return on sales
-12.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFMD stock price

How has the LifeMD stock price performed over time
Intraday
8.27%
1 week
1.06%
1 month
-15.66%
1 year
62.93%
YTD
-19.42%
QTD
-2.62%

Financial performance

How have LifeMD's revenue and profit performed over time
Revenue
$163.56M
Gross profit
$144.28M
Operating income
-$17.81M
Net income
-$23.36M
Gross margin
88.2%
Net margin
-14.3%
LFMD's operating margin has soared by 65% year-on-year but it is down by 15% since the previous quarter
LFMD's operating income has soared by 53% YoY but it is down by 23% from the previous quarter
The net margin has surged by 51% year-on-year but it has declined by 6% since the previous quarter
The gross profit has grown by 37% YoY and by 8% from the previous quarter

Growth

What is LifeMD's growth rate over time

Valuation

What is LifeMD stock price valuation
P/E
N/A
P/B
N/A
P/S
1.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
The EPS has grown by 41% YoY but it has contracted by 6% from the previous quarter
LifeMD's equity has shrunk by 124% QoQ but it has surged by 93% YoY
The revenue has grown by 33% YoY and by 7% from the previous quarter
The P/S is 22% below the 5-year quarterly average of 1.9 and 18% below the last 4 quarters average of 1.8

Efficiency

How efficient is LifeMD business performance
The ROS has soared by 56% YoY but it has contracted by 7% from the previous quarter
LFMD's ROA has soared by 55% year-on-year and by 4.1% since the previous quarter

Dividends

What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFMD.

Financial health

How did LifeMD financials performed over time
LifeMD's total assets is 2.2% more than its total liabilities
LifeMD's total assets has soared by 81% YoY and by 5% from the previous quarter
The quick ratio has soared by 69% YoY but it has contracted by 17% from the previous quarter
LifeMD's equity has shrunk by 124% QoQ but it has surged by 93% YoY
The debt is up by 21% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.